SCWorx Past Earnings Performance
Past criteria checks 0/6
SCWorx has been growing earnings at an average annual rate of 30.8%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 10% per year.
Key information
30.8%
Earnings growth rate
51.3%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | -10.0% |
| Return on equity | -78.3% |
| Net Margin | -108.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How SCWorx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3 | -4 | 2 | 0 |
| 30 Jun 24 | 3 | -4 | 2 | 0 |
| 31 Mar 24 | 4 | -4 | 2 | 0 |
| 31 Dec 23 | 4 | -4 | 3 | 0 |
| 30 Sep 23 | 4 | -2 | 3 | 0 |
| 30 Jun 23 | 4 | -1 | 3 | 0 |
| 31 Mar 23 | 4 | -2 | 3 | 0 |
| 31 Dec 22 | 4 | -2 | 4 | 0 |
| 30 Sep 22 | 4 | -2 | 4 | 0 |
| 30 Jun 22 | 4 | -3 | 5 | 0 |
| 31 Mar 22 | 5 | -4 | 6 | 0 |
| 31 Dec 21 | 5 | -4 | 6 | 0 |
| 30 Sep 21 | 5 | -3 | 5 | 0 |
| 30 Jun 21 | 5 | -4 | 6 | 0 |
| 31 Mar 21 | 5 | -7 | 8 | 0 |
| 31 Dec 20 | 5 | -7 | 8 | 0 |
| 30 Sep 20 | 5 | -10 | 10 | 0 |
| 30 Jun 20 | 6 | -8 | 9 | 0 |
| 31 Mar 20 | 5 | -7 | 8 | 0 |
| 31 Dec 19 | 6 | -11 | 13 | 0 |
| 30 Sep 19 | 5 | -9 | 11 | 0 |
| 30 Jun 19 | 4 | -8 | 9 | 0 |
| 31 Mar 19 | 4 | -6 | 7 | 0 |
| 31 Dec 18 | 3 | 0 | 1 | 0 |
| 30 Sep 18 | 3 | 0 | 0 | -1 |
| 31 Dec 17 | 3 | 0 | 0 | 0 |
| 31 Dec 16 | 2 | 0 | 1 | 1 |
Quality Earnings: 4R80 is currently unprofitable.
Growing Profit Margin: 4R80 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4R80 is unprofitable, but has reduced losses over the past 5 years at a rate of 30.8% per year.
Accelerating Growth: Unable to compare 4R80's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4R80 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: 4R80 has a negative Return on Equity (-78.26%), as it is currently unprofitable.